A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort
, , , et
08 mai 2019
À propos de cet article
Catégorie d'article: Research Article
Publié en ligne: 08 mai 2019
Pages: 219 - 224
Reçu: 12 févr. 2019
Accepté: 27 mars 2019
DOI: https://doi.org/10.2478/raon-2019-0020
Mots clés
© 2019 Stefan Janssen, Heinke C Hansen, Liesa Dziggel, Steven E Schild, Dirk Rades, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Janssen, Stefan
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany
Medical Practice for Radiotherapy and Radiation OncologyHannover, Germany
Hansen, Heinke C
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany
Dziggel, Liesa
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany
Schild, Steven E
Department of Radiation Oncology, Mayo Clinic ScottsdaleArizona, U.S.A.
Rades, Dirk
Department of Radiation Oncology, University Hospital LubeckLubeck, Germany